Skip to main content
ADHERIUM LIMITED logo

ADHERIUM LIMITED — Investor Relations & Filings

Ticker · ADR ISIN · AU000000ADR1 ASX Manufacturing
Open in API
Filings indexed 878 across all filing types
Latest filing 2019-08-29 Annual Report
Country AU Australia
Listing ASX ADR

About ADHERIUM LIMITED

https://www.adherium.com

Adherium Limited is a digital health company specializing in the development and commercialization of connected medical devices and software solutions for chronic respiratory management. The company's primary offering is the Hailie® platform, which consists of advanced sensors that attach to various inhaler medications to monitor usage and technique. These sensors transmit data via Bluetooth to a mobile application and a cloud-based portal, providing patients and healthcare providers with real-time insights into medication adherence and respiratory health trends. By facilitating remote patient monitoring and data-driven clinical decisions, Adherium aims to improve health outcomes for individuals living with asthma and chronic obstructive pulmonary disease (COPD). The platform is utilized by healthcare systems, pharmaceutical companies, and clinical research organizations to enhance patient engagement and optimize treatment efficacy.

Recent filings

Filing Released Lang Actions
Preliminary Final Report 10 pages 344.3KB
Annual Report Classification · 95% confidence The document is titled 'APPENDIX 4E PRELIMINARY FINAL REPORT FOR THE YEAR ENDED 30 JUNE 2019' and contains detailed financial statements including consolidated statements of profit or loss, financial position, changes in equity, and cash flows for the full fiscal year ended 30 June 2019. It includes comprehensive financial data, management commentary on results, audit status, and notes to the financial statements. The length of the document (15,000 characters) and the presence of full financial statements indicate this is a full annual financial report rather than a brief announcement or certification. Appendix 4E is a regulatory filing used in Australia to provide preliminary final results, which is effectively an annual report or equivalent. Therefore, the document fits the definition of an Annual Report (10-K equivalent). FY 2019
2019-08-29 English
Details of Principal Administrative Office Address 1
Regulatory Filings Classification · 95% confidence The document is a brief announcement regarding a change in the company's principal administrative office address. It references compliance with Listing Rule 3.14 but does not contain financial data, report content, or detailed management or governance information. The document length is short (1390 characters), and it is an administrative update rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2019-08-26 English
Adherium announces $1.8m secured notes financing 6 pages 225.9KB
Capital/Financing Update Classification · 95% confidence The document is an announcement by Adherium Limited regarding a $1.8 million secured notes financing. It details the terms of the secured notes, the ASX waiver granted for the security, and the option terms related to the convertible notes. The content focuses on the company's capital raising activities, including the issuance of debt notes, conversion features, security interests, and shareholder approval plans. There are no financial statements or comprehensive financial performance data presented, nor is this a transcript, management report, or legal proceeding update. The document is clearly an update on financing activities and capital structure changes. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and detail support a high confidence in this classification.
2019-08-21 English
Adherium and Summatix announce strategic initiative 3 pages 166.3KB
Regulatory Filings Classification · 95% confidence The document is a press release announcing a strategic initiative between Adherium and Summatix to enhance a digital health platform. It discusses business strategy, partnerships, product development, and market plans but does not contain financial statements, regulatory filings, voting results, or detailed financial data. It is not an earnings release, annual report, or any formal regulatory filing. The content is typical of a corporate announcement or business update rather than a formal financial or regulatory document. Therefore, it best fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous corporate announcements that do not fit other specific categories.
2019-08-19 English
Appendix 4C - quarterly 6 pages 438.4KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Appendix 4C Quarterly cash flow report to 30 June 2019' and is described as a quarterly cash flow report for the quarter and year ended 30 June 2019. It contains detailed financial data including cash flows from operating, investing, and financing activities, as well as reconciliation of cash and cash equivalents. The document references compliance with Listing Rule 4.7B and Australian Accounting Standards. The length of the document (12,765 characters) and the presence of substantive financial data confirm it is a financial report rather than a brief announcement or certification. The content and format align with an Interim / Quarterly Report (IR) as it covers a period shorter than a full fiscal year and includes actual financial statements and analysis. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q4 2019
2019-07-30 English
Adherium Receives further U.S. 510k Clearances 2 pages 155.1KB
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Adherium has received U.S. FDA 510(k) clearances for its medical devices. It discusses regulatory approvals, commercial rollout plans, and company progress but does not contain financial statements, detailed financial performance data, or management discussion of financial results. It is not an annual or interim report, earnings release, or any form of financial filing. The content is primarily an update on regulatory clearance and commercial progress, typical of a general regulatory announcement or company news release. Given the document length (4610 characters) and content, it does not qualify as a report publication announcement or a detailed financial report. Therefore, the best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and miscellaneous filings that do not fit other categories.
2019-07-14 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.